Stefanie Schreiber

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

Walter Reinisch, William J. Sandborn, Daniël W. Hommes et al. · Gut · 2011 · 874 citations · Full text

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

Elizabeth K. Speliotes, Cristen J. Willer, S. I. Berndt et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2010 · 767 citations · Full text

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

Andreas Charidimou, Grégoire Boulouis, Matthew P. Frosch et al. · The Lancet Neurology · 2022 · 597 citations · Full text

Cerebral Amyloid Angiopathy, Dementia, Neuroscience +6

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

Stefanie Schreiber, Walter Reinisch, J F Colombel et al. · Journal of Crohn s and Colitis · 2012 · 187 citations

Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model

Stefanie Schreiber, Celine Zoe Bueche, Cornelia Garz et al. · Experimental & Translational Stroke Medicine · 2013 · 140 citations · Full text